These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 17763546)
21. FDA notifications. Generic didanosine approved by FDA. AIDS Alert; 2008 Nov; 23(11):127-8. PubMed ID: 19043869 [No Abstract] [Full Text] [Related]
22. FDA notifications. FDA approves generic AZT. AIDS Alert; 2007 Jul; 22(7):79. PubMed ID: 17763553 [No Abstract] [Full Text] [Related]
23. Expanding access to investigational new therapies. Cohen C; Shevitz A; Mayer K Prim Care; 1992 Mar; 19(1):87-96. PubMed ID: 1594704 [TBL] [Abstract][Full Text] [Related]
24. FDA notifications. Generic emtricitabine is approved by the FDA. AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19222147 [No Abstract] [Full Text] [Related]
25. FDA notifications. FDA approved 3 generic formulations of stavudine. AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19219951 [No Abstract] [Full Text] [Related]
26. FDA notifications. Pediatric HIV infection guidelines are revised. AIDS Alert; 2008 Oct; 23(10):114-5. PubMed ID: 18935684 [No Abstract] [Full Text] [Related]
27. Drug watch. Whitson S Posit Aware; 2000; 11(1):18-9. PubMed ID: 11366337 [TBL] [Abstract][Full Text] [Related]
28. FDA notifications. Tentative approval granted for combo antiretroviral drug. AIDS Alert; 2007 Oct; 22(10):117-8. PubMed ID: 18416009 [No Abstract] [Full Text] [Related]
29. FDA notifications. FDA approves generic lamivudine. AIDS Alert; 2008 Dec; 23(12):142. PubMed ID: 19110688 [No Abstract] [Full Text] [Related]
30. Update on new antiretroviral drugs. An interview with Harold Kessler, M.D. by Matt Sharp. Kessler H Posit Aware; 2007; 18(6):22-4. PubMed ID: 18074429 [No Abstract] [Full Text] [Related]
31. FDA notifications. Generic lamivudine tentatively approved. AIDS Alert; 2008 Mar; 23(3):33. PubMed ID: 18661640 [No Abstract] [Full Text] [Related]
32. FDA notifications. FDA revises Baraclude labeling for HIV patients. AIDS Alert; 2007 Sep; 22(9):103-4. PubMed ID: 18415955 [No Abstract] [Full Text] [Related]
33. Is it time to rethink the expanded-access programs for HIV infection? Amorosa V; Tebas P J Infect Dis; 2007 Oct; 196(7):974-7. PubMed ID: 17763316 [TBL] [Abstract][Full Text] [Related]
34. FDA notifications. Entecavir revision made by FDA and BMS. AIDS Alert; 2007 Apr; 22(4):43. PubMed ID: 17595722 [No Abstract] [Full Text] [Related]
35. FDA notifications. FDA approval for generic lamivudine/zidovudine. AIDS Alert; 2008 Jan; 23(1):12. PubMed ID: 18572476 [No Abstract] [Full Text] [Related]
36. FDA notifications. FDA approves half-strength Kaletra. AIDS Alert; 2008 Jan; 23(1):10. PubMed ID: 18572474 [No Abstract] [Full Text] [Related]
37. FDA notifications. Tentative approval for generic stavudine, oral solution. AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415959 [No Abstract] [Full Text] [Related]
38. FDA notifications. Tentative approval granted of generic nevirapine. AIDS Alert; 2007 Sep; 22(9):104-5. PubMed ID: 18415956 [No Abstract] [Full Text] [Related]
39. FDA notifications. FDA approves generic stavudine. AIDS Alert; 2009 Mar; 24(3):34. PubMed ID: 19441156 [No Abstract] [Full Text] [Related]
40. Antiretroviral therapy. What does the future hold? Johnson D Women Alive; 2005; ():1-2, 6. PubMed ID: 16329210 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]